ES2171878T3 - Derivados de tiazolilbenzofurano y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de tiazolilbenzofurano y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2171878T3
ES2171878T3 ES97900432T ES97900432T ES2171878T3 ES 2171878 T3 ES2171878 T3 ES 2171878T3 ES 97900432 T ES97900432 T ES 97900432T ES 97900432 T ES97900432 T ES 97900432T ES 2171878 T3 ES2171878 T3 ES 2171878T3
Authority
ES
Spain
Prior art keywords
replaced
alcoxi
derivatives
tiazolilbenzofurano
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97900432T
Other languages
English (en)
Inventor
Masaaki Matsuo
Kazuo Okumura
Shinji Shigenaga
Hiroaki Nishimura
Hiroshi Matsuda
Daijiro Hagiwara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9601235.6A external-priority patent/GB9601235D0/en
Priority claimed from AUPO1111A external-priority patent/AUPO111196A0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2171878T3 publication Critical patent/ES2171878T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS DERIVADOS DE TIAZOLILBENZOFURANOS DE FORMULA (I) EN LA QUE R 1 ES ALQUILO INFER IOR, L ES UN ENLACE SENCILLO O ALQUILO INFERIOR OPCIONALMENTE SUSTITUIDO CON ARILO, OXO O HIDROXI, Y Q ES UN GRUPO HETEROCICLICO OPCIONALMENTE SUSTITUIDO CON UNO O MAS SUSTITUYENTES ADECUADOS; O ALCOXI INFERIOR SUSTITUIDO CON ARILO QUE ES SUSTITUIDO CON UNO O MAS SUSTITUYENTES ADECUADOS Y AL MENOS UNO DE ELLOS ES ALCOXI INFERIOR OPCIONALMENTE SUSTITUIDO CON CIANO, CARBOXI PROTEGIDO, CARBOXI, ALQUILENO INFERIOR, UN GRUPO HETEROCICLICO OPCIONALMENTE SUSTITUIDO CON OXO, O AMIDINO OPCIONALMENTE SUSTITUIDO CON HIDROXI O ALCOXI INFERIOR, O SU SAL, QUE POSEEN ACTIVIDADES COMO ANTAGONISTAS O INHIBIDORES DEL LEUCOTRINEO Y DEL SRS - A.
ES97900432T 1996-01-22 1997-01-17 Derivados de tiazolilbenzofurano y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2171878T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601235.6A GB9601235D0 (en) 1996-01-22 1996-01-22 Novel compounds
AUPO1111A AUPO111196A0 (en) 1996-07-18 1996-07-18 Novel compounds

Publications (1)

Publication Number Publication Date
ES2171878T3 true ES2171878T3 (es) 2002-09-16

Family

ID=25645218

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97900432T Expired - Lifetime ES2171878T3 (es) 1996-01-22 1997-01-17 Derivados de tiazolilbenzofurano y composiciones farmaceuticas que los contienen.

Country Status (12)

Country Link
US (1) US5994378A (es)
EP (2) EP1170009B1 (es)
JP (1) JP2000503984A (es)
KR (1) KR19990076788A (es)
CN (1) CN1209809A (es)
AT (2) ATE263561T1 (es)
CA (1) CA2244189A1 (es)
DE (2) DE69728581D1 (es)
EA (1) EA199800650A1 (es)
ES (1) ES2171878T3 (es)
HU (1) HUP9900424A2 (es)
WO (1) WO1997027190A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919413D0 (en) 1999-08-18 1999-10-20 Zeneca Ltd Chemical compounds
WO2001032621A1 (fr) * 1999-10-29 2001-05-10 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives d'indole, et medicaments contenant lesdits derives comme principe actif
IL158168A0 (en) * 2001-04-16 2004-03-28 Tanabe Seiyaku Co 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
CA2457054C (en) 2001-08-10 2011-10-11 Nippon Chemiphar Co., Ltd. Activator of peroxisome proliferator-activated receptor .delta.
DK1445258T3 (da) 2001-10-12 2009-10-12 Nippon Chemiphar Co Aktivator for peroxisomproliferator-aktiveret receptor delta
BRPI0511834A (pt) * 2004-07-14 2008-01-08 Ptc Therapeutics Inc métodos por tratar hepatite c
NZ554491A (en) * 2004-10-12 2009-07-31 Decode Genetics Ehf Sulfonamide peri-substituted bicyclics for occlusive artery disease
WO2006046683A1 (en) * 2004-10-25 2006-05-04 Astellas Pharma Inc. Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
NZ570528A (en) * 2006-02-15 2011-09-30 Allergan Inc Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
CN101460458A (zh) * 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
PL2014652T3 (pl) 2006-04-18 2015-02-27 Nippon Chemiphar Co Czynnik aktywujący receptor aktywowany przez proliferatory peroksysomów
DE102006021733A1 (de) * 2006-05-09 2007-11-22 Bayer Healthcare Ag 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
RU2008149518A (ru) * 2006-05-16 2010-06-27 Декод Дженетикс, Ехф. (Is) Способ получения 7-(акрилоил) индолов
DE102006043443A1 (de) * 2006-09-15 2008-03-27 Bayer Healthcare Ag Neue aza-bicyclische Verbindungen und ihre Verwendung
JP2010515750A (ja) * 2007-01-11 2010-05-13 アラーガン インコーポレイテッド スフィンゴシン−１−ホスフェート（ｓ１ｐ）受容体アンタゴニスト生物活性を有する６−置換インドール−３−カルボン酸アミド化合物
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
WO2009128558A1 (ja) 2008-04-15 2009-10-22 日本ケミファ株式会社 ペルオキシソーム増殖剤活性化受容体の活性化剤
DE102008063992A1 (de) 2008-12-19 2010-09-02 Lerner, Zinoviy, Dipl.-Ing. Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
NZ601967A (en) 2010-03-12 2015-03-27 Omeros Corp Pde10 inhibitors and related compositions and methods
CA2822357A1 (en) 2010-12-22 2012-06-28 Abbvie Inc. Hepatitis c inhibitors and uses thereof
MX2015010725A (es) 2013-02-21 2016-05-31 Adverio Pharma Gmbh Formas de metil {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo [3,4-b] piridino-3-il] pirimidino-5-il} metil carbamato.
NZ630810A (en) 2014-04-28 2016-03-31 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
PT3186233T (pt) * 2014-08-29 2021-12-02 Chdi Foundation Inc Sondas para imagem de proteína de huntingtina
EP3285760A4 (en) 2015-04-24 2018-09-26 Omeros Corporation Pde10 inhibitors and related compositions and methods
JP2018535969A (ja) 2015-11-04 2018-12-06 オメロス コーポレーション Ｐｄｅ１０阻害剤の固体状態形態
CN111372576A (zh) 2017-11-17 2020-07-03 塞尔利克斯生物私人有限公司 用于治疗眼部病症的组合物和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
JPH07179856A (ja) * 1993-12-21 1995-07-18 Canon Inc 液晶性化合物、これを含有する液晶組成物、該液晶組成物を用いた液晶素子並びにこれらを用いた表示方法、表示装置

Also Published As

Publication number Publication date
EP1170009A3 (en) 2002-01-16
EA199800650A1 (ru) 1999-02-25
DE69728581D1 (de) 2004-05-13
US5994378A (en) 1999-11-30
WO1997027190A1 (en) 1997-07-31
DE69712042T2 (de) 2002-10-02
EP0880519A1 (en) 1998-12-02
ATE263561T1 (de) 2004-04-15
ATE216384T1 (de) 2002-05-15
EP1170009A2 (en) 2002-01-09
JP2000503984A (ja) 2000-04-04
CN1209809A (zh) 1999-03-03
CA2244189A1 (en) 1997-07-31
DE69712042D1 (de) 2002-05-23
EP0880519B1 (en) 2002-04-17
KR19990076788A (ko) 1999-10-15
HUP9900424A2 (hu) 1999-05-28
EP1170009B1 (en) 2004-04-07

Similar Documents

Publication Publication Date Title
ES2171878T3 (es) Derivados de tiazolilbenzofurano y composiciones farmaceuticas que los contienen.
ES2161231T3 (es) Compuestos heterociclicos como antagonistas de bradiquinina.
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
AR029417A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
MX9401191A (es) Compuestos del grupo sulfamoilo y amidino, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
BR0016166A (pt) Compostos de diidropirimidina heterocìclicos
ES2173172T3 (es) Derivados de 1,3-dihidroindol-2-ona sustituidos en 3 por un grupo nitrogenado como agonistas y/o antagonistas de la vasopresina y/o de la octocina.
AR008861A1 (es) COMPUESTOS DE LACTAMA E IMIDA HETEROCICLICOS DE ARALQUILO Y ARALQUILEDENO, COMPUESTOS INTERMEDIARIOS PARA SU SíNTESIS, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
ES2159738T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
ES2185617T3 (es) Composiciones farmaceuticas de una sal de acido imidazolil-alquenoico y su uso como antagonistas de la angiotensina ii.
AR015103A1 (es) Compuestos derivados de 6,6-heterobiciclicos sustituidos y composiciones que los contienen e intermediarios
ES2103289T3 (es) Derivados de pirimidina y composiciones herbicidas que los contienen.
ES2191117T3 (es) Sulfonamidas herbicidas.
MX9400070A (es) Compuestos heterociclicos, un procedimiento para prepararlos, su uso y composiciones farmaceuticas que los contienen.
AR005532A1 (es) Compuestos de dihalopropeno, las composiciones insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2180932T3 (es) Derivados de camptotecina y su uso como agentes antitumorales.
GR76413B (es)
CO5210898A1 (es) Combinaciones sienrgicas de fungicida del tipo valinamida y fenamidona
ES2112483T3 (es) 4-aril-4-hidroxi-tetrahidropiranos y 3-aril-3-hidroxi-tetrahidrofuranos como inhibidores de 5-lipoxigenasa.
ES2077878T3 (es) Derivados substituidos de amidas de aminoacidos, su obtencion y su empleo como fungicidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 880519

Country of ref document: ES